ORGANIC
LETTERS
2003
Vol. 5, No. 11
1995-1997
Total Synthesis of (+)-Strictifolione
Samir BouzBouz and Janine Cossy*
Laboratoire de Chimie Organique Associe´ au CNRS, ESPCI, 10 rue Vauquelin,
75231 Paris, Cedex 05, France
Received April 10, 2003
ABSTRACT
The synthesis of (+)-strictifolione was achieved from 3-phenylproprionaldehyde by using enantioselective allyltitanations to control the stereogenic
centers at C6, C4′, and C6′ and a cross-methathesis to control the configuration of the double bond at C1′−C2′.
Recently, a number of 5,6-dihydro-R-pyrone derivatives
having an alkyl side chain at the C6 position, with 1,3- or
1,5-diol units, have been isolated from plants. The biological
activities of these compounds have not been completely
studied, but it seems that the activity depends on the
substituents on the alkyl side chain. Some of these com-
pounds have been found to exhibit antifungal activity such
as passifloricin A,1 to inhibit the cell cycle progression in
the M-phase and to be an immunosuppressive agent such as
(-)-pironetin,2 to exhibit cytotoxic activity such as callystatin
A3 and leptomycin B,4 or to be an anticancer agent such as
fostriecin5 (Figure 1). In the course of our program to
synthesize 6-substituted 5,6-dihydro-R-pyrones, we became
interested in the synthesis of (+)-strictifolione.
(1) Echeverri, F.; Arango, V.; Quin˜ones, W.; Torres, F.; Escobar, G.;
Rosero, Y.; Archbold, R. Phytochemistry 2001, 56, 88.
(2) (a) Kobayashi, S.; Tsuchiya, K.; Harada, T.; Nishide, M.; Kurokawa,
T.; Nakagawa, T.; Shimada, N.; Kobayashi, K. J. Antibiot. 1994, 47, 697.
(b) Kobayashi, S.; Tsuchiya, K.; Kurokawa, T.; Nakagawa, T.; Shimada,
N.; Iitaka, Y. J. Antibiot. 1994, 47, 703. (c) Tsuchiya, K.; Kobayashi, S.;
Harada, T.; Nishikiori, T.; Nakagawa, T.; Tatsuta, K. J. Antibiot. 1997, 50,
259.
(3) (a) Kobayashi, M.; Higuchi, K.; Murakami, N.; Tajima, H.; Aoki,
S.; Tetrahedron Lett. 1997, 38, 2859. (b) Murakami, N.; Wang, W.; Aoki,
S.; Kobayashi, M. Tetrahedron Lett. 1997, 38, 5533.
Figure 1.
(4) (a) Hamamoto, T.; Seto, H.; Beppu, T. J. Antibiot. 1983, 36, 646.
(b) Yoshida, M.; Nishikawa, M.; Nishi, K.; Abe, K.; Horinouchi, S.; Beppu,
T.; Shimada, N.; Kobayashi, K. Exp. Cell. Res. 1990, 187, 150.
(+)-Strictifolione was isolated from Cryptocaria strictifolia
and has shown to display antifungal activity.6 Its structure
(5) (a) Hokanson, G. C.; French, J. C. J. Org. Chem. 1985, 50, 462. (b)
Scheithauer, W.; Von Hoff, D. D.; Clark, G. M.; Shillis, J. L.; Elslager, E.
F. Eur. J. Cancer Clin. Oncol. 1986, 22, 921. (c) Fry, D. W.; Boritzki, T.
J.; Jackson, R. C. Cancer Chemother. Pharmacol. 1984, 13, 171. (d)
Leopold, W. R.; Shillis, J. L.; Mertus, A. E.; Nelson, J. M.; Roberts, B. J.;
Jackson, R. C. Cancer Res. 1984, 44, 1928.
1
was elucidated from the H NMR spectra of an acetonide
(6) Juliawaty, L. D.; Kitajima, M.; Takayama, H.; Achmad, S. A.; Aimi,
N. Phytochemistry 2000, 54, 989-993.
10.1021/ol034619s CCC: $25.00 © 2003 American Chemical Society
Published on Web 05/06/2003